Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Generation and protective efficacy of a cold-adapted attenuated avian H9N2 influenza vaccine.

Wei Y, Qi L, Gao H, Sun H, Pu J, Sun Y, Liu J.

Sci Rep. 2016 Jul 26;6:30382. doi: 10.1038/srep30382.

2.

Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.

Hughes HR, Vincent AL, Brockmeier SL, Gauger PC, Pena L, Santos J, Braucher DR, Perez DR, Loving CL.

Clin Vaccine Immunol. 2015 Oct;22(10):1109-20. doi: 10.1128/CVI.00358-15.

3.

Virus-vectored influenza virus vaccines.

Tripp RA, Tompkins SM.

Viruses. 2014 Aug 7;6(8):3055-79. doi: 10.3390/v6083055. Review.

4.

Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use.

Lee DH, Park JK, Song CS.

Clin Exp Vaccine Res. 2014 Jul;3(2):133-9. doi: 10.7774/cevr.2014.3.2.133. Review.

5.

Host defense mechanism-based rational design of live vaccine.

Jang YH, Byun YH, Lee KH, Park ES, Lee YH, Lee YJ, Lee J, Kim KH, Seong BL.

PLoS One. 2013 Oct 2;8(10):e75043. doi: 10.1371/journal.pone.0075043.

6.

Virus-like particles as universal influenza vaccines.

Kang SM, Kim MC, Compans RW.

Expert Rev Vaccines. 2012 Aug;11(8):995-1007. Review.

7.

Protective effect of Korean red ginseng extract on the infections by H1N1 and H3N2 influenza viruses in mice.

Yoo DG, Kim MC, Park MK, Song JM, Quan FS, Park KM, Cho YK, Kang SM.

J Med Food. 2012 Oct;15(10):855-62. doi: 10.1089/jmf.2012.0017.

8.
9.

Microneedles for drug and vaccine delivery.

Kim YC, Park JH, Prausnitz MR.

Adv Drug Deliv Rev. 2012 Nov;64(14):1547-68. doi: 10.1016/j.addr.2012.04.005. Review.

10.

Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection.

Okamoto S, Matsuoka S, Takenaka N, Haredy AM, Tanimoto T, Gomi Y, Ishikawa T, Akagi T, Akashi M, Okuno Y, Mori Y, Yamanishi K.

Clin Vaccine Immunol. 2012 Jul;19(7):979-90. doi: 10.1128/CVI.00016-12.

11.

Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice.

Lorenzo ME, Hodgson A, Robinson DP, Kaplan JB, Pekosz A, Klein SL.

Vaccine. 2011 Nov 15;29(49):9246-55. doi: 10.1016/j.vaccine.2011.09.110.

12.

Systems biology of vaccination for seasonal influenza in humans.

Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, Means AR, Kasturi SP, Khan N, Li GM, McCausland M, Kanchan V, Kokko KE, Li S, Elbein R, Mehta AK, Aderem A, Subbarao K, Ahmed R, Pulendran B.

Nat Immunol. 2011 Jul 10;12(8):786-95. doi: 10.1038/ni.2067.

13.

Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections.

Chaussee MS, Sandbulte HR, Schuneman MJ, Depaula FP, Addengast LA, Schlenker EH, Huber VC.

Vaccine. 2011 May 12;29(21):3773-81. doi: 10.1016/j.vaccine.2011.03.031.

14.

Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets.

Chen GL, Min JY, Lamirande EW, Santos C, Jin H, Kemble G, Subbarao K.

J Infect Dis. 2011 Apr 1;203(7):930-6. doi: 10.1093/infdis/jiq144.

15.

Changes in the viral distribution pattern after the appearance of the novel influenza A H1N1 (pH1N1) virus in influenza-like illness patients in Peru.

Laguna-Torres VA, Gómez J, Aguilar PV, Ampuero JS, Munayco C, Ocaña V, Pérez J, Gamero ME, Arrasco JC, Paz I, Chávez E, Cruz R, Chavez J, Mendocilla S, Gomez E, Antigoni J, Gonzalez S, Tejada C, Chowell G, Kochel TJ; Peru Influenza working group..

PLoS One. 2010 Jul 27;5(7):e11719. doi: 10.1371/journal.pone.0011719.

16.
17.

Controlling influenza by cytotoxic T-cells: calling for help from destroyers.

Schotsaert M, Ibañez LI, Fiers W, Saelens X.

J Biomed Biotechnol. 2010;2010:863985. doi: 10.1155/2010/863985.

18.

Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.

Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR.

Pharm Res. 2011 Jan;28(1):135-44. doi: 10.1007/s11095-010-0134-6.

19.

Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs.

Masic A, Booth JS, Mutwiri GK, Babiuk LA, Zhou Y.

J Virol. 2009 Oct;83(19):10198-210. doi: 10.1128/JVI.00926-09.

20.

Blocking interhost transmission of influenza virus by vaccination in the guinea pig model.

Lowen AC, Steel J, Mubareka S, Carnero E, García-Sastre A, Palese P.

J Virol. 2009 Apr;83(7):2803-18. doi: 10.1128/JVI.02424-08.

Items per page

Supplemental Content

Support Center